Agentix Corp (AGTX)
0.0354
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Agentix EPS Diluted (Quarterly): 0.0002 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0002 |
| September 30, 2023 | -0.0045 |
| June 30, 2023 | -0.01 |
| March 31, 2023 | -0.02 |
| December 31, 2022 | -0.01 |
| September 30, 2022 | -0.01 |
| June 30, 2022 | -0.0042 |
| February 28, 2022 | -0.05 |
| December 31, 2021 | -0.01 |
| November 30, 2021 | -0.0048 |
| August 31, 2021 | -0.01 |
| May 31, 2021 | -0.005 |
| February 28, 2021 | -0.02 |
| November 30, 2020 | -0.01 |
| May 31, 2020 | -0.38 |
| February 29, 2020 | -0.009 |
| November 30, 2019 | -0.0042 |
| August 31, 2019 | -0.0081 |
| May 31, 2019 | -0.03 |
| February 28, 2019 | -0.04 |
| November 30, 2018 | -0.022 |
| Date | Value |
|---|---|
| August 31, 2018 | -0.0154 |
| May 31, 2018 | -37.43 |
| February 28, 2018 | -0.10 |
| November 30, 2017 | -0.10 |
| August 31, 2017 | -0.10 |
| May 31, 2017 | -0.10 |
| February 28, 2017 | -0.30 |
| November 30, 2016 | -0.20 |
| August 31, 2016 | -0.20 |
| May 31, 2016 | -0.30 |
| February 29, 2016 | 0.0006 |
| November 30, 2015 | -0.0006 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | -0.0255 |
| February 28, 2015 | -0.10 |
| November 30, 2014 | -0.10 |
| August 31, 2014 | -0.10 |
| May 31, 2014 | -0.10 |
| February 28, 2014 | -0.10 |
| November 30, 2013 | -0.10 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.38
Minimum
May 2020
0.0002
Maximum
Dec 2023
-0.0316
Average
-0.01
Median
Nov 2020
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp | -0.14 |
| AIM ImmunoTech Inc | -0.12 |
| IGC Pharma Inc | -0.09 |
| NovaBay Pharmaceuticals Inc | -5.25 |
| Protalix BioTherapeutics Inc | -0.06 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.0064M |
| Total Expenses (Quarterly) | 0.0158M |
| Enterprise Value | 1.517M |
| Earnings Yield | -96.78% |
| Normalized Earnings Yield | -126.85 |